CYRNQ — Cyren Share News
0.000.00%
Last trade - 00:00TechnologyHighly SpeculativeMicro Cap
- $0.00m
- -$4.80m
- $31.19m
Brief: Cyren Files Prospectus Relates To Proposed Resale Of Up To 6.4 Million Ordinary Shares By Selling Shareholders
Brief: Cyren Sees Q4 Revenue $7.3 Million
Cyren Ltd reports results for the quarter ended in September - Earnings Summary
U.S. STOCKS ON THE MOVE-Levi Strauss, Snap Inc, AT&T, Conagra, Cyren
Cyren surges as Nasdaq extends timeline to fulfill requirements to stay listed
Brief: Cyren Ltd Files For Resale Of Up To 29.2 Million Ordinary Shares By Selling Stockholder - SEC Filing
U.S. STOCKS ON THE MOVE-Offerpad Solutions, Leap Therapeutics, Phio Pharmaceuticals
Revenues For Q2 Of 2021 Were $7.6 Million, Compared To $9.2 Million During Q2 Of 2020
Cyren Ltd reports results for the quarter ended in June - Earnings Summary
Cyren Ltd expected to post a loss of 6 cents a share - Earnings Preview
Cyren Ltd expected to post a loss of 6 cents a share - Earnings Preview
Cyren Ltd expected to post a loss of 6 cents a share - Earnings Preview
Cyren Ltd expected to post a loss of 6 cents a share - Earnings Preview
Cyren Ltd reports results for the quarter ended in March - Earnings Summary
Brief: Cyren Posts Q1 Loss Per Share Of $0.06
Cyren Ltd expected to post a loss of 5 cents a share - Earnings Preview
Brief: Cyren - On April 8, 2021, Co Received Written Notice From Listing Qualifications Department Of Nasdaq
Brief: Cyren Ltd Currently Estimates That Revenue For Q4 Was $8.4 Mln
On Jan 26, J. CFO Michael Myshrall, Notified Co Of His Intention To Resign From His Position Effective February 28, 2021